Inhaled nitric oxide 45 mcg/kg of ideal body weight per hour was effective for improving physical activity in patients at risk for pulmonary hypertension associated with fibrotic interstitial lung disease.
All articles by Brandon May
Patients with severe eosinophilic asthma who are treated with mepolizumab and subsequently stop treatment have increased blood eosinophil counts and increased exacerbations, among other negative clinical outcomes.
In patients with ARDS, a positive net fluid balance is associated with increased odds of mortality and more ventilation use compared with patients with ARDS and a negative net fluid balance.
While the incidence of minor bleeding events during endobronchial ultrasound with transbronchial needle aspiration is higher in patients who receive antiplatelet medications, these medications are still warranted in select patients.
In patients with sepsis admitted to the ICU who were classified as obese experienced longer durations of ventilator use and had a higher risk for ARDS compared with patients with a normal BMI.
Once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol provided greater increases in lung function compared to once-daily fluticasone furoate/vilanterol in patients with poorly controlled asthma.
FEV1 increased in patients with aspirin-tolerant asthma while on standard asthma treatment but declined in patients with aspirin-exacerbated respiratory disease.
Prenatal exposure to calcium carbonate antacids was associated with the development of food protein-induced allergic proctocolitis, a type of delayed inflammatory gut food allergy to protein, in offspring.
Treatment with mepolizumab is associated with improvements in asthma exacerbation rates and health-related quality of life in patients with severe eosinophilic asthma and comorbid nasal polyps, sinusitis, or allergic rhinitis.
A review provides an update on current and emerging concepts of management for excessive hand sweating to help clinicians optimize therapeutic decision making.